Oil prices steady with US inventory build, Fed decision in focus

Oil prices stabilized in Asian trade, cooling recent gains, driven by an unexpected 1.5 million barrel build in U.S. oil inventories reported by API, which raised demand concerns. This inventory build, contrasting expectations for a draw, weighed on prices alongside market caution ahead of the Federal Reserve's rate decision and a week packed with key economic data, including U.S. nonfarm payrolls and China's PMI.

Analysis

Oil prices are exhibiting signs of stabilization following a recent rally, checked by emerging concerns over demand in the United States. Data from the American Petroleum Institute (API) revealed an unexpected build in U.S. crude inventories of approximately 1.5 million barrels, directly contradicting market expectations for a 2.5 million barrel draw. This reversal from the prior week's draw raises questions about fuel consumption strength and has introduced a bearish sentiment, which is being amplified by broader market caution ahead of a Federal Reserve interest rate decision. While the Fed is widely expected to hold rates steady, a strengthening U.S. dollar is exerting downward pressure on commodity prices. The market's uncertainty is further compounded by a dense calendar of upcoming economic data, including official inventory figures, U.S. nonfarm payrolls, and PMI data from China, which will be critical in shaping the demand outlook. Although geopolitical factors such as potential U.S. sanctions on Russian oil buyers previously provided price support, these concerns are currently being overshadowed by macroeconomic and inventory-related headwinds. It is also noted that while the article's headline reports a significant negative development for Novo Nordisk, with a cut to its full-year guidance, the textual content focuses exclusively on the dynamics of the energy market.

Key Decisions for Investors

• Given the unexpected 1.5 million barrel build in U.S. crude inventories reported by the API, investors should exercise caution on near-term bullish oil positions pending further clarity on demand.
• Closely monitor key upcoming catalysts for directional conviction, specifically the official EIA inventory data, the Federal Reserve's policy statement, U.S. nonfarm payrolls, and China's PMI figures.
• For those holding Novo Nordisk (NVO), the headline's report of a guidance cut represents a significant bearish signal that requires immediate due diligence to assess the impact on the company's fundamental outlook.